OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company’s first AI agent that can act autonomously on the web. But OpenAI is not Altman’s only ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Contrary to Musk’s claims, Sam Altman, CEO of OpenAI, had his own statements to make on X. Altman posted that Musk’s claims ...

Sticks and Stones Yesterday, we reported that tech moguls Elon Musk and Sam Altman are already falling over themselves to win the favor of returning president Donald Trump. That drama has since ...

Tensions between technology leaders Elon Musk and OpenAI CEO Sam Altman were on full display this week after the Tesla CEO slammed the new artificial intelligence (AI) infrastructure project, ...